Lundbeck
HLUN-B.CO
#2346
Rank
NZ$10.56 B
Marketcap
$10.92
Share price
0.98%
Change (1 day)
20.87%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.58

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.57. In 2022 the company made an earnings per share (EPS) of $0.43 a decrease over its 2021 EPS that were of $0.98.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.5834.07%
2022$0.43-55.47%
2021$0.98-51.83%
2020$2.03-28.01%
2019$2.82-44.08%
2018$5.0451.94%
2017$3.31126.64%
2016$1.46-120.84%
2015-$7.025622.18%
2014-$0.12-110.03%
2013$1.22-28.08%
2012$1.70-52.1%
2011$3.55-1.31%
2010$3.5915.61%
2009$3.11